Third Rock Ventures Iv, L.P. Magenta Therapeutics, Inc. (MGTA) insider trading activity

Third Rock Ventures Iv, L.P. is > 10% Shareholder of Magenta Therapeutics, Inc.. Currently has a direct ownership of 3.06 Million shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Feb 08, 2023, when has been sold 1,500,000 shares (Common Stock) at a price of $0.82 per share, resulting in proceeds of $1,230,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.06M

0% 3M change

0% 12M change

Total Value Held $0

Third Rock Ventures IV, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2023	SELL Open market or private sale	$1,230,000 $0.82 p/Share	1,500,000 Reduced 32.91%	3,058,204 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,826,000 $0.83 p/Share	2,200,000 Reduced 32.55%	4,558,204 Common Stock
Aug 25 2021	SELL Other acquisition or disposition	-	1,250,000 Reduced 15.61%	6,758,204 Common Stock
Jun 25 2018	BUY Conversion of derivative security	-	7,911,455 Added 49.7%	8,008,204 Common Stock

Also insider at

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

TNGX

Tango Therapeutics, Inc. Healthcare

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV